Drugmakers seek incentives to develop antibiotics to fight 'superbugs'
They also call for diagnostic tests so that antibacterial drugs are not used needlessly
New York
MORE than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant "superbugs."
In a declaration that is being released on Thursday at the World Economic Forum in Davos, Switzerland, the companies say tha…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Harvard applications drop 5% after tumultuous year on campus
Australia wants businesses to diversify after China scraps wine tariffs
Japan drugmaker reports two more deaths in supplement scare
Chanel flap bag now costs more than 10,000 euros in Paris
Florida governor, Disney reach settlement in lawsuit over special district
Kobayashi Pharma ordered to recall red yeast rice pills after 2 deaths